Health
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas – ABC News
AstraZeneca and Oxford University’s potential COVID-19 vaccine produces a strong immune response in those aged over 70.
Oxford University and AstraZeneca’s potential COVID-19 vaccine produced a strong immune response in older adults, newly published data has showed, with researchers expecting to release late-stage trial results by Christmas.
Key points:
- Late stage Oxford-AstraZeneca trials have shown it develops antibody and T-cell responses in elderly patients
- Rival drugmakers Pfizer-BioNTech and Moderna have recently pushed ahead in the race for a COVID vaccine
- Researchers report no serious side effects from the…
Continue Reading
-
General19 hours agoWA government rolls out suite of housing assistance ahead of state budget
-
Business21 hours agoLeading brokers name 3 ASX shares to buy today 16 June 2025
-
Noosa News20 hours agoPolice investigate fire at Borrodell Estate winery restaurant near Orange
-
Noosa News16 hours agoAssault appeal, Sippy Downs – Queensland Police News